Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combating COVID-19 with mesenchymal stem cell therapy

14 May 2020

Abstract excerpt

The COVID-19 disease is caused by a positive stranded RNA virus called SARS-CoV-2. The virus mainly targets the pulmonary epithelial cells as it's initial site of infection by letting its surface spike protein interact and bind to the host ACE2 receptor. The internalization and gradual replication of the virus results in an exaggerated immune response triggering release of many pro-inflammatory cytokines and...

Topics

Join the communities discussing this publication.

COVID-19 Clinical Research Studies
Long-Term Effects of COVID-19
Mesenchymal stem cell research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32420049
DOI: 10.1016/j.btre.2020.e00467

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combating COVID-19 with mesenchymal stem cell therapyPMID 32420049Read ↗

COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based TherapySemantic proximity Read ↗

Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future.Semantic proximity Read ↗

The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 PatientsSemantic proximity Read ↗

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expectSemantic proximity Read ↗

MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreakSemantic proximity Read ↗

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospectsSemantic proximity Read ↗

Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue RegenerationSemantic proximity Read ↗

Mesenchymal Stem Cells Impact on COVID-19 Patients Immune System, an Ex Vivo StudySemantic proximity Read ↗

Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatmentSemantic proximity Read ↗

Engineering mesenchymal stem cells with neutralizing and anti- inflammation dual-capability against SARS-CoV-2 infectionSemantic proximity Read ↗

Exosomes: Emerging implementation of nanotechnology for detecting and managing novel corona virus- SARS-CoV-2Semantic proximity Read ↗

Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.